Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
Marianthi Georgitsi(University of Helsinki), Lauri A. Aaltonen(Varsinais-Suomen Sairaanhoitopiiri), Robert J. Weil(Cleveland Clinic), Jan Lubiński(Tumour Institute of Tuscany), Wolfgang Saeger(Universität Hamburg), Ernesto De Menis(Inserm), Pia Vahteristo(University of Helsinki), Olga Lucewicz(International Hereditary Cancer Center), Anniina Raitila(University of Helsinki), Markus J. Mäkinen(Oulu University Hospital), Grzegorz Zieliński(Wojskowy Instytut Medycyny Lotniczej), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), A. Wasik(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego), Virpi Launonen(University of Helsinki), Rob B. van der Luijt(Institute for Quality and Efficiency in Health Care), Timo Sane(Helsinki University Hospital), Karoliina Tuppurainen(University of Oulu), Ralf Paschke(University of Calgary), Outi Vierimaa(Oulu University Hospital), Auli Karhu(University of Helsinki)
Cited by 182
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k